We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Genco Shipping & Trading
GNK
$1.12B
| $867K | ﹤0.01% |
+69,161
| New | +$1.1M |
|
752
Healthpeak Properties
DOC
$14.3B
| $861K | ﹤0.01% |
37,583
-7,276
| -16% | -$192K |
|
|
CFB
753
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $861K | ﹤0.01% |
65,994
| – | – |
|
754
Jones Lang LaSalle
JLL
$16.9B
| $857K | ﹤0.01% |
5,675
-27,455
| -83% | -$4.78M |
|
755
Independent Bank
INDB
$4.04B
| $856K | ﹤0.01% |
+11,484
| New | +$928K |
|
756
H.B. Fuller
FUL
$3.24B
| $851K | ﹤0.01% |
14,161
-700
| -5% | -$44.6K |
|
757
Sana Biotechnology
SANA
$1.11B
| $848K | ﹤0.01% |
141,319
-16,170
| -10% | -$117K |
|
758
National Bank Holdings
NBHC
$1.94B
| $845K | ﹤0.01% |
22,836
-6,073
| -21% | -$244K |
|
759
Beazer Homes USA
BZH
$874M
| $843K | ﹤0.01% |
87,228
-74,126
| -46% | -$1.02M |
|
|
UNIT
760
Uniti Group
UNIT
$2.38B
| $843K | ﹤0.01% |
121,343
-23,159
| -16% | -$215K |
|
761
Universal Health Services
UHS
$10.1B
| $841K | ﹤0.01% |
+9,538
| New | +$986K |
|
762
Tactile Systems Technology
TCMD
$541M
| $838K | ﹤0.01% |
107,634
+33,385
| +45% | +$278K |
|
|
GMS
763
DELISTED
GMS Inc
GMS
| $832K | ﹤0.01% |
20,800
-1,200
| -5% | -$57.4K |
|
764
BancFirst
BANF
$3.87B
| $828K | ﹤0.01% |
9,252
+1,416
| +18% | +$145K |
|
765
Beam Therapeutics
BEAM
$2.74B
| $827K | ﹤0.01% |
17,357
+861
| +5% | +$49.1K |
|
766
Marten Transport
MRTN
$1.24B
| $826K | ﹤0.01% |
+43,089
| New | +$862K |
|
767
Murphy USA
MUSA
$10.3B
| $823K | ﹤0.01% |
2,995
-780
| -21% | -$218K |
|
|
CHUY
768
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $823K | ﹤0.01% |
35,516
-500
| -1% | -$11.2K |
|
769
Futu Holdings
FUTU
$14.7B
| $819K | ﹤0.01% |
21,951
+11,547
| +111% | +$504K |
|
770
Amalgamated Financial
AMAL
$1.52B
| $818K | ﹤0.01% |
36,276
| – | – |
|
771
Berkshire Hathaway Class A
BRK.A
$1.08T
| $813K | ﹤0.01% |
2
| – | – |
|
772
Watts Water Technologies
WTS
$12.8B
| $812K | ﹤0.01% |
6,459
+230
| +4% | +$31.2K |
|
|
SGFY
773
DELISTED
Signify Health, Inc.
SGFY
| $807K | ﹤0.01% |
27,700
-378,485
| -93% | -$8.72M |
|
774
Greif
GEF
$5.04B
| $806K | ﹤0.01% |
13,525
| – | – |
|
775
BorgWarner
BWA
$13.8B
| $803K | ﹤0.01% |
+29,059
| New | +$937K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.